Overview
Leprosy reversal reaction (RR) refers to inflammatory episodes that can occur in previously treated leprosy patients, often triggered by immune reconstitution following treatment cessation or modification. These reactions can affect skin, nerves, and other tissues, mimicking active leprosy or presenting as Type 1 (reversal reaction) or Type 2 (irregular skin reaction) [Not directly covered in provided abstracts].Diagnosis
Clinical presentation includes skin lesions, nerve thickening, and functional impairment.
Histopathological examination may show granulomatous inflammation with or without acid-fast bacilli.
Nerve conduction studies can assess peripheral neuropathy severity [Not directly covered in provided abstracts].Management
Corticosteroids are first-line treatment to control inflammation; typical initial dose ranges from prednisolone 40-60 mg/day, tapered based on response [Not directly covered in provided abstracts].
Immunosuppressants like dapsone or clofazimine may be used adjunctively in severe cases [Not directly covered in provided abstracts].
Symptomatic treatment for complications such as pain management and physical therapy for nerve function recovery [Not directly covered in provided abstracts].Special Populations
Pregnancy: Specific management guidelines for RR during pregnancy are not detailed in the provided abstracts [Not directly covered in provided abstracts].
Pediatrics: Management principles apply but dosage adjustments and monitoring for growth and development are crucial [Not directly covered in provided abstracts].
Elderly: Increased vigilance for complications and careful monitoring of steroid side effects are recommended [Not directly covered in provided abstracts].
Comorbidities: Management should consider interactions with existing conditions; close monitoring and individualized treatment plans are essential [Not directly covered in provided abstracts].Key Recommendations
Initiate corticosteroid therapy promptly for managing leprosy reversal reactions to control inflammation (Evidence: Expert opinion) [Not directly covered in provided abstracts].
Tailor immunosuppressive therapy based on severity, considering adjuncts like dapsone for refractory cases (Evidence: Expert opinion) [Not directly covered in provided abstracts].
Regularly monitor patients for both therapeutic efficacy and side effects, especially in vulnerable populations like the elderly and pregnant women (Evidence: Expert opinion) [Not directly covered in provided abstracts].References
1 Hua V, Bole R, Oh P, Parekh N, Vij SC, Lundy SD. The Diversity of Vasectomy Reversal Providers and Their Web-based Advertising Habits in the United States. Urology 2023. link
2 Bitonti MT, Rumbarger RL, Absher RK, Curran LM. Prospective Evaluation of a Fixed-Dose 4-Factor Prothrombin Complex Concentrate Protocol for Urgent Vitamin K Antagonist Reversal. The Journal of emergency medicine 2020. link
3 Nseyo U, Patel N, Hsieh TC. Vasectomy Reversal Surgical Patterns: An Analysis of the American Board of Urology Case Logs. Urology 2017. link
4 Grey BR, Thompson A, Jenkins BL, Payne SR. UK practice regarding reversal of vasectomy 2001-2010: relevance to best contemporary patient management. BJU international 2012. link
5 Sauer MV, Zeffer KB, Bustillo MC, Buster JE. Sterilization reversals performed by fellows in training: what success rates can we reasonably expect?. Microsurgery 1987. link
6 Raspa RW, Burbige KA, Hensle TW. The sex reversal syndrome (the XX male patient). The Journal of urology 1985. link47036-4)